.png)
The Other Side of the ARRIVE Trial : One Charlotte & Lake Norman area doula's Perspective
- The Statesville Doula
- 22 hours ago
- 5 min read
What Your Doctor May Not Be Telling You About 39-Week Induction
As a doula in the Charlotte area, I often hear the same concern from clients during pregnancy:
“My doctor recommended induction at 39 weeks because of the ARRIVE Trial.”
If you’re pregnant, this conversation may already feel familiar. Sometimes, your doctor may not even mention the trial and just state that they'll induce you at 39 weeks without explanation. Ultimately, the ARRIVE Trial is frequently used to support routine 39-week inductions, often presented as the safest or most responsible choice.
Because this study is referenced so often, I want to slow things down and break it apart. My goal is to help you understand the other side of the ARRIVE Trial, i.e. the limitations, context, and nuances that are often left out or oversimplified in quick prenatal appointments with your Charlotte and surrounding area providers.
As a Charlotte and Lake Norman area doula, my role is never to tell you what you should do. It’s to make sure you have complete, evidence-based information so you can make informed decisions that align with your body, your baby, and your birth goals, whether that includes waiting for labor, considering induction, or planning a VBAC.
Let’s take a closer look.
*This is informational ONLY and should not be taken as medical advice. Please always have an honest discussion with your provider on your preferences. You have the right to informed consent AND refusal. Shared decision making is a right and a must.*
What Was the ARRIVE Trial?
The ARRIVE Trial (A Randomized Trial of Induction Versus Expectant Management) was published in 2018 and examined whether elective induction at 39 weeks reduced the likelihood of cesarean birth in low-risk, first-time pregnancies.
Participants were divided into two groups:
One group was induced at 39 weeks
The other waited for labor to begin on its own unless a medical reason for induction arose later
The study found a slightly lower cesarean rate in the induction group (18.6%) compared to those who waited (22.2%).
This finding has led many hospitals — including those serving Charlotte and Lake Norman — to normalize or encourage routine 39-week inductions.
But context matters.
Why the ARRIVE Trial Has Important Limitations
1. The ARRIVE Trial Does Not Apply to VBAC
This study excluded anyone with a previous cesarean birth. That means it offers no guidance for VBAC and should not be used when counseling someone planning a vaginal birth after cesarean.
If you’re seeking a VBAC, it's always worth seeking out a doula and it’s important to know that VBAC care requires individualized risk assessment, patience, and provider support — not blanket induction policies based on research that doesn’t include you.
2. The Participants Were Highly Selective
Only a small percentage of eligible pregnant women chose to participate. Those who enrolled were:
Low risk
First-time parents
Comfortable being randomized to induction
This matters because it limits how applicable the results are to the broader population of people searching for support in Charlotte who want personalized, relationship-based care and not necessarily induction births.
3. The Study Took Place in High-Resource Hospitals with NO MIDWIVES
The ARRIVE Trial was conducted in large, well-staffed hospitals with:
Strict induction protocols
Continuous provider availability
Consistent monitoring and support
No midwives who may have offered a different level of support and recommendation than that of OBGYNS. We have to wonder if there was bias here.
These conditions are not guaranteed in every hospital. As a Charlotte doula, I see first hand how induction outcomes vary widely depending on staffing levels, provider philosophy, and hospital culture — especially outside academic centers.
4. The Difference in Cesarean Rates Was Small
While often framed as a major finding, the reduction in cesarean birth was only about 3–4% and there were no significant differences in serious complications for birthing mothers or babies.
For many families, this modest statistical difference may not outweigh:
Longer labors
Increased interventions
Limited movement and monitoring
A birth experience that feels less physiological
5. Birth Experience Was Not Measured
The ARRIVE Trial did not evaluate:
Satisfaction with the birth experience
Emotional well-being
Breastfeeding outcomes
Birth trauma or sense of autonomy
As someone often found when families search for a doula in Charlotte and Lake Norman, I know these outcomes matter deeply — and deserve to be part of the decision-making process.
How the ARRIVE Trial Is Commonly Misused
The ARRIVE Trial showed that induction at 39 weeks can be safe for some people under specific conditions. It did not show that induction is superior to spontaneous labor, nor did it recommend routine induction for everyone.
Unfortunately, many families are presented with induction as a default rather than a choice — without a full discussion of alternatives, risks, or the option to wait when parent and baby are healthy.
What This Means for Your Birth
Whether you are planning your first birth, exploring VBAC, or simply hoping to avoid unnecessary intervention, you deserve individualized, informed care.
As a doula in Charlotte, NC, my role is to help you:
Understand the evidence behind recommendations
Ask informed questions
Navigate hospital policies
Feel confident advocating for your preferences
Helpful questions to ask your provider include:
“Is this induction recommended because of my health or hospital policy?”
“What are the risks and benefits of waiting in my situation?”
“How does my cervix or baby’s position affect induction success?”
FAQs About the ARRIVE Trial
Is induction at 39 weeks safer than waiting?
For some low-risk, first-time pregnancies in high-resource hospitals, induction at 39 weeks appears safe. However, it is not proven to be safer for everyone, and waiting is still a valid option when mom and baby are healthy.
Does the ARRIVE Trial apply to VBAC?
No. The ARRIVE Trial excluded people with prior cesareans and should not be used to guide VBAC care.
Why do so many doctors recommend 39-week induction?
Many providers rely on simplified interpretations of the study or hospital policy. Time constraints and institutional pressure can limit nuanced counseling.
Can I decline a 39-week induction?
Yes. Unless there is a medical indication, induction is a choice. You have the right to informed consent and shared decision-making.
Support from Statesville Doula & Lactation -
Doula support in Charlotte, Lake Norman, and Hickory areas of NC
The ARRIVE Trial is one piece of evidence — not a rule, not a mandate, and not the full picture.
If you’re searching for "doula near me," a "VBAC doula", or a "doula in Charlotte or Lake Norman, NC," I provide evidence-based, judgment-free support centered on informed consent and trust. I would be honored to help you navigate this piece of your journey.
Ready to Talk Through Your Options?
If you want support navigating induction conversations, VBAC planning, or hospital birth in Charlotte or Lake Norman, I’d love to connect and let’s talk about what feels right for your birth.
Peace, love, and babies,
Staci
Comments